SAN DIEGO, April 06, 2021 (News) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the 20th Annual Needham Virtual Healthcare Conference. David A. Weber, Ph.D., president and CEO of Otonomy, will present a company overview on Tuesday, April 13, 2021 at 4:30 p.m. ET (1:30 p.m. PT).
A live audio webcast of the presentation will be available through the Events page of the company’s website (www.otonomy.com). An archived webcast of the presentation will also be available on the same web page shortly after the live event.
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice President404.firstname.lastname@example.org
Investor InquiriesWestwicke ICRRobert H. UhlManaging Director858.email@example.com
- Check the latest Health news updates and information.
- Please share this news Otonomy to Present at the Needham Virtual Healthcare Conference Nasdaq:OTIC with your friends and family to support us your one share helps us a lot.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week